微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2026-09-30 | 1.86% | 148.44% | 12.73% | 89/159 | 3.55% | 翰宇药业 | 52.19% | 行业排名> |
| 2026-06-30 | 1.65% | 155.93% | 685.71% | 90/159 | 1.36% | 泽璟制药 | 44.02% | 行业排名> |
| 2026-03-31 | 0.21% | 113.91% | 104.93% | 117/159 | 0.06% | 泽璟制药 | 45.29% | 行业排名> |
| 2025-12-31 | -4.26% | 20.67% | -10.94% | 111/159 | -4.32% | 兴齐眼药 | 38.62% | 行业排名> |
| 2025-09-30 | -3.84% | -618.92% | -30.17% | 124/159 | 1.69% | 兴齐眼药 | 32.91% | 行业排名> |
| 2025-06-30 | -2.95% | -1280% | -95.36% | 125/159 | 0.34% | 翰宇药业 | 18.95% | 行业排名> |
| 2025-03-31 | -1.51% | -1106.67% | 71.88% | 129/159 | -0.34% | 翰宇药业 | 11.39% | 行业排名> |
| 2024-12-31 | -5.37% | -516.28% | -825.68% | 115/159 | -9.4% | 百利天恒 | 181.27% | 行业排名> |
| 2024-09-30 | 0.74% | -76.28% | 196% | 106/159 | 4.26% | 百利天恒 | 186.1% | 行业排名> |
| 2024-06-30 | 0.25% | -87.68% | 66.67% | 111/159 | 2.68% | 百利天恒 | 186.89% | 行业排名> |
| 2024-03-31 | 0.15% | -83.15% | -88.37% | 111/159 | 2.33% | 百利天恒 | 188.56% | 行业排名> |
| 2023-12-31 | 1.29% | -39.72% | -58.65% | 96/159 | -0.94% | 小方制药 | 41.8% | 行业排名> |
| 2023-09-30 | 3.12% | 28.93% | 53.69% | 91/159 | 2.36% | 拓新药业 | 20.51% | 行业排名> |
| 2023-06-30 | 2.03% | 12.15% | 128.09% | 83/159 | 1.49% | 拓新药业 | 19.87% | 行业排名> |
| 2023-03-31 | 0.89% | 18.67% | -58.41% | 95/159 | 1.37% | 拓新药业 | 19.91% | 行业排名> |
| 2022-12-31 | 2.14% | 65.89% | -11.57% | 97/159 | 0.84% | 小方制药 | 55.57% | 行业排名> |
| 2022-09-30 | 2.42% | 26.7% | 33.7% | 91/159 | 2.87% | 福元医药 | 25.41% | 行业排名> |
| 2022-06-30 | 1.81% | 364.1% | 141.33% | 92/159 | 2.21% | 小方制药 | 34.81% | 行业排名> |
| 2022-03-31 | 0.75% | 327.27% | -41.86% | 101/159 | 1.59% | 退市金泰 | 10.74% | 行业排名> |
| 2021-12-31 | 1.29% | 112.18% | -32.46% | 103/159 | 0.87% | ST人福 | 6.82% | 行业排名> |
| 2021-09-30 | 1.91% | 170.22% | 389.74% | 106/159 | 4.45% | 小方制药 | 71.99% | 行业排名> |
| 2021-06-30 | 0.39% | 114.23% | 218.18% | 116/159 | 2.99% | 汇宇制药 | 39.25% | 行业排名> |
| 2021-03-31 | -0.33% | 75.19% | 96.88% | 109/159 | 2.48% | 汇宇制药 | 28.14% | 行业排名> |
| 2020-12-31 | -10.59% | -541.25% | -289.34% | 120/159 | 3.82% | 哈三联 | 27.17% | 行业排名> |
| 2020-09-30 | -2.72% | -160.04% | 0.73% | 102/159 | 3.15% | 汇宇制药 | 55.94% | 行业排名> |
| 2020-06-30 | -2.74% | -189.84% | -106.02% | 115/159 | 4.28% | 中哲精化 | 45.32% | 行业排名> |
| 2020-03-31 | -1.33% | -178.7% | -155.42% | 98/159 | 2.23% | 汇宇制药 | 31.9% | 行业排名> |
| 2019-12-31 | 2.4% | -59.32% | -47.02% | 105/159 | 2.62% | 誉衡药业 | 35.56% | 行业排名> |
| 2019-09-30 | 4.53% | -20.8% | 48.52% | 72/159 | 7.58% | 奥赛康 | 35% | 行业排名> |
| 2019-06-30 | 3.05% | -13.84% | 80.47% | 69/159 | 5.02% | 奥赛康 | 28.15% | 行业排名> |
| 2019-03-31 | 1.69% | -2.31% | -71.36% | 64/159 | 2.44% | 宏源药业 | 21.91% | 行业排名> |
| 2018-12-31 | 5.9% | 26.61% | 3.15% | 78/159 | 7.16% | 奥赛康 | 9.7% | 行业排名> |
| 2018-09-30 | 5.72% | 91.95% | 61.58% | 59/159 | 7.2% | 奥赛康 | 40.69% | 行业排名> |
| 2018-06-30 | 3.54% | 136% | 104.62% | 63/159 | 4.62% | 信立泰 | 25.93% | 行业排名> |
| 2018-03-31 | 1.73% | 620.83% | -62.88% | 63/159 | 2.57% | 昂利康 | 15.91% | 行业排名> |
| 2017-12-31 | 4.66% | -75.25% | 56.38% | 87/159 | 9.61% | 奥赛康 | 12.08% | 行业排名> |
| 2017-09-30 | 2.98% | 2% | 98.67% | 77/159 | 8.3% | 一品红 | 31.62% | 行业排名> |
| 2017-06-30 | 1.5% | -85.51% | 525% | 85/159 | 5.55% | 丽珠集团 | 49.43% | 行业排名> |
| 2017-03-31 | 0.24% | 2% | -98.73% | 80/159 | 2.11% | 中哲精化 | 54.24% | 行业排名> |
| 2016-12-31 | 18.83% | -61.29% | 81.93% | 24/159 | 6.11% | 华东医药 | 7.2% | 行业排名> |
| 2016-06-30 | 10.35% | 2% | -78.72% | 12/159 | 3.56% | ST南新 | 81.7% | 行业排名> |